title: PARP inhibitors for chemoprevention--letter.
authors.affiliation: Department of Surgery, The Jefferson Pancreas, Biliary and Related Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania.
authors.forename: Saswati N
authors.initials: SN
authors.lastname: Chand
authors.affiliation: Department of Surgery, The Jefferson Pancreas, Biliary and Related Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania. Department of Surgery and Department of Pharmacology and Experimental Therapeutics, Thomas Jefferson University.
authors.forename: Fernando F
authors.initials: FF
authors.lastname: Blanco
authors.affiliation: Department of Surgery, The Jefferson Pancreas, Biliary and Related Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania.
authors.forename: Masaya
authors.initials: M
authors.lastname: Jimbo
authors.affiliation: Department of Surgery, The Jefferson Pancreas, Biliary and Related Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania.
authors.forename: Theodore N
authors.initials: TN
authors.lastname: Tsangaris
authors.affiliation: Department of Surgery, The Jefferson Pancreas, Biliary and Related Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania.
authors.forename: Massimo
authors.initials: M
authors.lastname: Cristofanilli
authors.affiliation: Department of Surgery, The Jefferson Pancreas, Biliary and Related Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania.
authors.forename: Charles J
authors.initials: CJ
authors.lastname: Yeo
authors.affiliation: Department of Surgery, The Jefferson Pancreas, Biliary and Related Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania.
authors.forename: Jordan M
authors.initials: JM
authors.lastname: Winter
authors.affiliation: Lombardi Comprehensive Cancer Center, Department of Oncology, Georgetown University, Washington, DC.
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Pishvaian
authors.affiliation: Department of Surgery, The Jefferson Pancreas, Biliary and Related Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania. jonathan.brody@jefferson.edu.
authors.forename: Jonathan R
authors.initials: JR
authors.lastname: Brody
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D019313:BRCA1 Protein / Q000502:physiology*; D001562:Benzimidazoles / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D015674:Mammary Neoplasms, Animal / Q000517:prevention & control*; D010793:Phthalazines / Q000627:therapeutic use*; D010879:Piperazines / Q000627:therapeutic use*; D000067856:Poly(ADP-ribose) Polymerase Inhibitors
chemical_list: D000970:Antineoplastic Agents; D019313:BRCA1 Protein; D001562:Benzimidazoles; D010793:Phthalazines; D010879:Piperazines; D000067856:Poly(ADP-ribose) Polymerase Inhibitors